The global obesity treatment market is projected to register a robust CAGR during the forecast period, between 2021 and 2028. Obesity refers to a disease that involves an excess amount of fat in the body. This increases the risk of other health problems such as heart diseases, diabetes, high blood pressure, and certain cancers. Obesity treatment involves assessment and management of the disease. The treatment for obesity is a complex process but it starts mainly with a healthy lifestyle and exercise. The diet quality can be improved by maintaining a proper proportion of the food products and reducing the intake of food rich in sugar or fats. Medications are also used while maintaining a balanced diet. However, if diet, medications and exercise don’t curb the disease, then the chances for gastric balloon or surgery increases, in order to reduce stomach volume or length of the intestines that reduces the ability of the body to absorb nutrients from the food.
Market Trends, Drivers, Restraints, and Opportunities:
- Increasing government initiatives to spread awareness about fitness and healthy lifestyle is driving the market growth.
- High cost of surgeries and the risk of poor medical facilities and services, especially in low-income countries can create challenges for the growth of the market.
- Rising demand for minimal invasive surgeries, aggressive marketing strategies by key players in the market and reimbursement policies are spurring the market growth.
Scope of the report:
The report on the global obesity treatment market includes an assessment of the market, size, share, trends, segments, and regional markets. Overview and dynamics have been included in the report.
Global Obesity Treatment Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast
2018 & 2019
Lifestyle Changes (Dietary Changes and Exercise), Surgical and Implant Devices (Gastric Bypass Surgery, Gastric Band, Gastric Balloon, Electrical Stimulation Systems, and Gastric Emptying Systems), Medication Therapies (Combination Drug Therapies and Individual/Satiety Drugs)
Asia Pacific, North America, Europe, Latin America, and Middle East & Africa
Market scope, analysis, share, competitive analysis, growth facts, restraints, opportunities, and revenue forecast
Obesity Treatment Market Segment Insights:
Dietary segment to grow at a robust pace during the forecast period
Based on lifestyle changes, the obesity treatment market can be segmented into dietary changes and exercise. The dietary segment is forecasted to account a large market share due to the focus of the people on improving their diet intake. The importance of maintaining a balanced diet and the intake of vital nutrients has been established by many health organisations as well as the government. Changes in the diet, by reducing the level of sugar or fatty foods can help in treatment of obesity. On the other hand, practicing exercises helps the body in defeating diseases and keeps the mind and body healthy.
Gastric bypass surgery segment to exhibit a high CAGR
On the basis of surgery and implant devices, the obesity treatment market can be divided into gastric bypass surgery, gastric balloon, gastric band, electrical stimulation systems, and gastric emptying systems. The gastric bypass surgery is anticipated to exhibit a high CAGR during the forecast period. Gastric bypass surgery is a preferred method for the treatment of obesity due to fast recovery time, improved psychological status, and improved longevity. A person with stage 2 diabetes or sleep apnea is qualified for a gastric bypass surgery.
Combination drug therapies segment to expand at a significant growth rate during the forecast period
In terms of medication therapies, the market can be divided into individual/satiety drugs and combination drug therapies. The combination drug therapies segment is projected to hold a major market share during the forecast period. This is due to the combined effect of therapy and rising cases of obesity. The composition of combination drugs propels the treatment process. However, the individual drugs segment is anticipated to expand at a steady rate owing to its low cost than the combination drug therapy.
North America to dominate the market
Based on regions, the obesity treatment market can be categorized as Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North American is projected to hold a significant market share due to the rising cases of obesity in the countries such as the US and Canada. Strong government support and growth in the obese population has further attributed to the growth of the market in the region. Key players are investing heavily in R&D projects for better medicines and therapies to ensure better results among patients. The rise in awareness about obesity and the commercialization of invasive surgeries has also aided to the growth of the market in North America.
By Lifestyle Changes
By Medication Therapies
- Combination Drug Therapies
- Individual/ Satiety Drugs
By Surgical and Implant Devices
- Gastric Bypass Surgery
- Gastric Band
- Gastric Balloon
- Electrical Stimulation Systems
- Gastric Emptying Systems
- Asia Pacific
- North America
- Latin America
- Middle East & Africa
By Key Players
- NutriSystem Inc.
- Kellogg Company
- Ethicon Inc.
- Atkins Nutritionals Inc.
- Herbalife Ltd.
- Covidien plc
- Apollo Endosurgery
- Amer Sports
- Johnson Health Technology Ltd
Key players in the obesity treatment market include NutriSystem Inc., Kellogg Company, Ethicon Inc., Atkins Nutritionals Inc., Herbalife Ltd., Covidien plc, Apollo Endosurgery, Amer Sports, and Johnson Health Technology Ltd. These players are actively engaged in several market development strategies including collaborations, agreements, mergers & acquisitions, production capacity expansion, new product launches, and partnerships to increase their market share.